These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
194 related items for PubMed ID: 8222093
41. A comparison between the use of recombinant hirudin and heparin during hemodialysis. van Wyk V, Badenhorst PN, Luus HG, Kotzé HF. Kidney Int; 1995 Oct; 48(4):1338-43. PubMed ID: 8569097 [Abstract] [Full Text] [Related]
42. Clinical pharmacology of intravenously administered recombinant desulfatohirudin (CGP 39393) in healthy volunteers. Marbet GA, Verstraete M, Kienast J, Graf P, Hoet B, Tsakiris DA, Silling-Engelhardt G, Close P. J Cardiovasc Pharmacol; 1993 Sep; 22(3):364-72. PubMed ID: 7504125 [Abstract] [Full Text] [Related]
48. Recombinant hirudin (lepirudin) as anticoagulant in intensive care patients treated with continuous hemodialysis. Fischer KG, van de Loo A, Böhler J. Kidney Int Suppl; 1999 Nov; (72):S46-50. PubMed ID: 10560805 [Abstract] [Full Text] [Related]
49. [Antithrombotic effects of recombinant hirudin in mice and its mechanism]. Cao WL, Li J. Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2018 Apr 08; 34(4):371-374. PubMed ID: 30788948 [Abstract] [Full Text] [Related]
53. Comparison of enoxaparin, hirulog, and heparin as adjunctive antithrombotic therapy during thrombolysis with rtPA in the stenosed canine coronary artery. Leadley RJ, Kasiewski CJ, Bostwick JS, Bentley R, McVey MJ, White FJ, Perrone MH, Dunwiddie CT. Thromb Haemost; 1997 Oct 01; 78(4):1278-85. PubMed ID: 9364998 [Abstract] [Full Text] [Related]
54. Hirudin in acute myocardial infarction. Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9B trial. Antman EM. Circulation; 1996 Sep 01; 94(5):911-21. PubMed ID: 8790025 [Abstract] [Full Text] [Related]
55. Monitoring of recombinant hirudin: assessment of a plasma-based ecarin clotting time assay. Pötzsch B, Hund S, Madlener K, Unkrig C, Müller-Berghaus G. Thromb Res; 1997 Jun 01; 86(5):373-83. PubMed ID: 9211628 [Abstract] [Full Text] [Related]
56. Phase I study of Solulin, a novel recombinant soluble human thrombomodulin analogue. van Iersel T, Stroissnig H, Giesen P, Wemer J, Wilhelm-Ogunbiyi K. Thromb Haemost; 2011 Feb 01; 105(2):302-12. PubMed ID: 21103657 [Abstract] [Full Text] [Related]
57. Recombinant hirudin (HBW 023): biological data of ten patients with severe venous thrombo-embolism. Bridey F, Dreyfus M, Parent F, Bros A, Fischer AM, Camez A, Simonneau G, Duroux P, Meyer D. Am J Hematol; 1995 May 01; 49(1):67-72. PubMed ID: 7741141 [Abstract] [Full Text] [Related]
59. Construction and functional evaluation of hirudin derivatives with low bleeding risk. Zhang C, Yu A, Yuan B, Dong C, Yu H, Wang L, Wu C. Thromb Haemost; 2008 Feb 01; 99(2):324-30. PubMed ID: 18278181 [Abstract] [Full Text] [Related]